123 related articles for article (PubMed ID: 2420036)
1. Effect of intratracheally administered anticancer drugs on lung hydroxyproline content.
Kehrer JP; Lee YC; Smith RD
Toxicol Lett; 1986 Jan; 30(1):63-70. PubMed ID: 2420036
[TBL] [Abstract][Full Text] [Related]
2. Intratracheal versus intravenous administration of bleomycin in mice: acute effects.
Lindenschmidt RC; Tryka AF; Godfrey GA; Frome EL; Witschi H
Toxicol Appl Pharmacol; 1986 Aug; 85(1):69-77. PubMed ID: 2425458
[TBL] [Abstract][Full Text] [Related]
3. Enhanced acute lung damage in mice following administration of 1,3-bis(2-chloroethyl)-1-nitrosourea.
Kehrer JP; Klein-Szanto AJ
Cancer Res; 1985 Nov; 45(11 Pt 2):5707-13. PubMed ID: 4053044
[TBL] [Abstract][Full Text] [Related]
4. Biphasic effects of free radical scavengers against bleomycin-induced pulmonary fibrosis.
Fujita M; Mizuta Y; Ikegame S; Ouchi H; Ye Q; Harada E; Inoshima I; Yoshimi M; Watanabe K; Nakanishi Y
Pulm Pharmacol Ther; 2008 Oct; 21(5):805-11. PubMed ID: 18655842
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of two mouse models of lung fibrosis induced by intratracheal instillation and intratracheal aerosol administration of bleomycin].
Li W; Hu Y; Yuan W; Li L; Huang W
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Feb; 32(2):221-5. PubMed ID: 22381763
[TBL] [Abstract][Full Text] [Related]
6. The effect of adipose stem cell therapy on pulmonary fibrosis induced by repetitive intratracheal bleomycin in mice.
Lee SH; Lee EJ; Lee SY; Kim JH; Shim JJ; Shin C; In KH; Kang KH; Uhm CS; Kim HK; Yang KS; Park S; Kim HS; Kim YM; Yoo TJ
Exp Lung Res; 2014 Apr; 40(3):117-25. PubMed ID: 24624895
[TBL] [Abstract][Full Text] [Related]
7. Peplomycin sulfate and pulmonary fibrosis: hydroxyproline, uronic acid, proline hydroxylase and glucosamine 6-phosphate synthetase in lungs of hamsters treated with peplomycin.
Yoshida A; Yamada T; Hiramatsu M; Kiuchi H; Sekiya S; Kawaguchi T; Yamamoto K; Yu SY
J Antibiot (Tokyo); 1983 Aug; 36(8):1067-75. PubMed ID: 6195141
[TBL] [Abstract][Full Text] [Related]
8. [Effects of antisense oligonucleotide to nuclear factor-kappaB on the development of bleomycin-induced pulmonary fibrosis and IL-4 expression therein: experiment with mice].
Zhang XY; Zhou Y; Liu WQ; Zhao L; Li SQ
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):195-9. PubMed ID: 17425852
[TBL] [Abstract][Full Text] [Related]
9. Bleomycin and cyclophosphamide toxicity in mice with damaged lung tissue.
Kehrer JP
Toxicology; 1989 Jul; 57(1):69-82. PubMed ID: 2473544
[TBL] [Abstract][Full Text] [Related]
10. Bleomycin-induced pulmonary fibrosis is attenuated by an antibody against KL-6.
Xu L; Yang D; Zhu S; Gu J; Ding F; Bian W; Rong Z; Shen C
Exp Lung Res; 2013 Aug; 39(6):241-8. PubMed ID: 23672275
[TBL] [Abstract][Full Text] [Related]
11. High dose continuous infusion of bleomycin in mice: a new model for drug-induced pulmonary fibrosis.
Harrison JH; Lazo JS
J Pharmacol Exp Ther; 1987 Dec; 243(3):1185-94. PubMed ID: 2447265
[TBL] [Abstract][Full Text] [Related]
12. Resistance of fibrogenic responses to glucocorticoid and 2-methoxyestradiol in bleomycin-induced lung fibrosis in mice.
Langenbach SY; Wheaton BJ; Fernandes DJ; Jones C; Sutherland TE; Wraith BC; Harris T; Schuliga MJ; McLean C; Stewart AG
Can J Physiol Pharmacol; 2007 Jul; 85(7):727-38. PubMed ID: 17823636
[TBL] [Abstract][Full Text] [Related]
13. Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse.
Yasui H; Gabazza EC; Tamaki S; Kobayashi T; Hataji O; Yuda H; Shimizu S; Suzuki K; Adachi Y; Taguchi O
Am J Respir Crit Care Med; 2001 Jun; 163(7):1660-8. PubMed ID: 11401891
[TBL] [Abstract][Full Text] [Related]
14. Bleomycin-induced pulmonary injury in mice deficient in SPARC.
Savani RC; Zhou Z; Arguiri E; Wang S; Vu D; Howe CC; DeLisser HM
Am J Physiol Lung Cell Mol Physiol; 2000 Oct; 279(4):L743-50. PubMed ID: 11000135
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of liposomal alpha-tocopherol against bleomycin-induced lung injury.
Suntres ZE; Shek PN
Biomed Environ Sci; 1997 Mar; 10(1):47-59. PubMed ID: 9099426
[TBL] [Abstract][Full Text] [Related]
16. T cell independence of bleomycin-induced pulmonary fibrosis.
Helene M; Lake-Bullock V; Zhu J; Hao H; Cohen DA; Kaplan AM
J Leukoc Biol; 1999 Feb; 65(2):187-95. PubMed ID: 10088601
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary hydroxyproline content and production following treatment of mice with O,S,S-trimethyl phosphorodithioate.
Kehrer JP; Lee YC
Toxicol Lett; 1987 Oct; 38(3):321-7. PubMed ID: 3660435
[TBL] [Abstract][Full Text] [Related]
18. Potentiating effects of oxygen in lungs damaged by methylcyclopentadienyl manganese tricarbonyl, cadmium chloride, oleic acid, and antitumor drugs.
Hakkinen PJ; Morse CC; Martin FM; Dalbey WE; Haschek WM; Witschi HR
Toxicol Appl Pharmacol; 1983 Jan; 67(1):55-69. PubMed ID: 6189266
[TBL] [Abstract][Full Text] [Related]
19. An investigation of possible models for the production of progressive pulmonary fibrosis in the rat. The effects of repeated intratracheal instillation of bleomycin.
Brown RF; Drawbaugh RB; Marrs TC
Toxicology; 1988 Sep; 51(1):101-10. PubMed ID: 2457963
[TBL] [Abstract][Full Text] [Related]
20. Dietary fish oil inhibits bleomycin-induced pulmonary fibrosis in the rat.
Kennedy JI; Chandler DB; Fulmer JD; Wert MB; Grizzle WE
Exp Lung Res; 1989 Mar; 15(2):315-29. PubMed ID: 2468480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
